CHELMSFORD, Mass., Dec. 8, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today with great sadness that Mr. A. Clinton Allen, Director, passed away unexpectedly on December 6, 2020. Mr. Allen served on Brooks’ Board of Directors since 2003. He was 76. “We are all saddened by the sudden passing of our friend and longtime board member,... Read more
CHELMSFORD, Mass., Dec. 3, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has acquired Trans-Hit Biomarkers Inc. (THB), a worldwide biospecimen procurement service provider based in Montreal Canada. THB has an extensive collection capability for biospecimens and clinical samples through a worldwide partner network of clinical sites and biobanks. THB is enabled... Read more
Germantown, Maryland, and Hilden, Germany, November 16, 2020 –QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that will help healthcare professionals quickly identify and differentiate between patients with common seasonal respiratory infections and COVID-19. With the Northern Hemisphere in the grip of flu... Read more
CHELMSFORD, Mass., Nov. 16, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in Stephens Annual Investment Conference 2020 on Thursday, November 19, 2020 which includes a 45-minute webcast beginning at 9:00 a.m. ET. The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. A replay... Read more
Non-invasive sample collection and batch processing to test symptomatic and asymptomatic individuals – a breakthrough in COVID-19 testing WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 12, 2020– PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens... Read more
Brooks Automation Reports its Fourth Quarter and Year-End Results of Fiscal 2020, Ended September 30, 2020, and Announces Quarterly Cash Dividend Significant Earnings Growth Driven by Operating Margin Expansion and Double-Digit Revenue Growth in Both Life Sciences and Semiconductor Solutions CHELMSFORD, Mass., Nov. 10, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results... Read more
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 9, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 QuantiVacTM ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1... Read more
AUSTIN, Texas, Nov. 5, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT FINANCIAL HIGHLIGHTS Total revenue for the third quarter of $106.1M, a 35% increase over Q3 2019, driven... Read more
Brooks Automation Announces Fiscal 2020 Fourth Quarter and Year-End Earnings Conference Call and Webcast CHELMSFORD, Mass., Oct. 27, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2020 fourth quarter and year-end earnings which ended on September 30, 2020 on Tuesday, November 10, 2020 after the market closes. The Company will host a conference... Read more
New kit provides highly sensitive and efficient approach for studying mitophagyimpairment in conditions such as Parkinson’s and Alzheimer’s WALTHAM, Mass. – October 26, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry’s first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying defective... Read more